Company news
Regencell Bioscience Holdings Limited (NASDAQ:RGC) news
Regencell Bioscience Holdings Limited news releases on 6ix. Latest, Sep 15, 2026: Regal Launches Regal Rewards+ to Bring Moviegoers More Value and Flexibility
Press releases & updates
Regal Launches Regal Rewards+ to Bring Moviegoers More Value and Flexibility
September 15, 2026
Regal Celebrates Record-Breaking Summer with First-Ever Rewards Week
August 31, 2026
"The Odyssey" Drives Regal's Biggest Audience Share of the Year
July 20, 2026
Regencell Bioscience : Announces First Half 2024 Financial Results Form 6 K
June 20, 2024
Regencell Bioscience : Resignation of Yi-Chung Chao as Director - Form 6-K
January 2, 2024
Regencell Bioscience : Form of Letter of Lock-up Undertaking - Form 6-K
December 15, 2023
Regencell Bioscience : Announces First Half 2023 Management Financial Results - Form 6-K
June 15, 2023
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial
September 11, 2022
Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
May 17, 2022
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
May 15, 2022
Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network
February 28, 2022
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
February 15, 2022
Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors
December 12, 2021
Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index
November 21, 2021
Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO
November 21, 2021
Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment
September 1, 2021
Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option
August 19, 2021
Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders
August 4, 2021
Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering
July 19, 2021
Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering
July 14, 2021